Skip to main content
  • Notice of Privacy Incident
  • Medicaid Provider Termination Alert: Revalidation deadlines are approaching. Failure by providers to revalidate will lead to termination and payment suspension. Check your account now at https://impact.illinois.gov/ to learn if your required revalidation is due this month. More revalidation information here.

Drugs and Therapeutics (D & T) Committee Meeting Results for: March 18, 2015

Drug Name Review Type Committee Recommendation Prior Approval Status � Final Determination
Viekira Pak New Drug Initial Review Require Prior Approval Prior Approval Required
Zontivity New Drug Initial Review Require Prior Approval Prior Approval Required
Harvoni New Drug Initial Review Add to Preferred Status Preferred and Require Prior Approval
Savaysa New Drug Initial Review Require Prior Approval Prior Approval Required
Grastek New Drug Initial Review Require Prior Approval Prior Approval Required
Ragwitek New Drug Initial Review Require Prior Approval Prior Approval Required
Plegridy New Drug Initial Review Require Prior Approval Prior Approval Required
Orbactiv New Drug Initial Review Remove Prior Approval Requirement Prior Approval Required